Zhang, Y., Xu, J., Hua, J., Liu, J., Liang, C., Meng, Q., . . . Shi, S. (2019). A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. J Immunother Cancer.
Styl ChicagoZhang, Yiyin, et al. "A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma." J Immunother Cancer 2019.
Citace podle MLAZhang, Yiyin, et al. "A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma." J Immunother Cancer 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..